Skip to main content

Detail

Victoria Stanek, MSc

Department of Otorhinolaryngology (Division of General Otorhinolaryngology)
Position: Research Assistant

ORCID: 0000-0003-3445-0934
T +43 1 40400 34380
victoria.stanek@meduniwien.ac.at

Keywords

Allergy and Immunology; Head and Neck Neoplasms; Nasal Polyps; Sinusitis

Research group(s)

Selected publications

  1. Villazala-Merino, S. et al., 2020. Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation. Journal of Allergy and Clinical Immunology, 145(3), pp.958,
  2. Waltl, E.E. et al., 2020. Primary Nasal Epithelial Cells From Allergic and Non-allergic Individuals Show Comparable Barrier Function. Allergy, Asthma & Immunology Research, 12(2), p.364. Available at: http://dx.doi.org/10.4168/aair.2020.12.2.364.
  3. Schneider, S. et al., 2020. Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease. Journal of Clinical Medicine, 9(4), p.925. Available at: http://dx.doi.org/10.3390/jcm9040925.
  4. Eckl-Dorna, J. et al., 2019. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response. EBioMedicine, 50, pp.421,
  5. Schnoell, J. et al., 2021. Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma. Investigational New Drugs. Available at: http://dx.doi.org/10.1007/s10637-021-01190-7.